A. Nahum, K. Hirsch, M. Danilenko, C. K. Watts, O. W. Prall, J. Levy and Y. Sharoni, “Lycopene Inhibition of Cell Cycle Progression in Breast and Endometrial Cancer Cells Is Associated with Reduction in Cyclin D Levels and Retention of p27 (Kip1) in the Cyclin E-cdk2 Complex,” Oncogene, Vol. 20, No. 26, 2001, pp. 3428-3436. doi:10.1038/sj.onc.1204452

has been cited by the following article:

• TITLE: Antiproliferative Activity of “Lycopersicon esculentum” Leaves (Var. Paul Robenson): Preliminary Study

  AUTHORS: Carmela Saturnino, Annalisa Spagnuolo, Chiara Palladino, Ada Popolo, Giuseppina Tommonaro, Rocco De Prisco, Aldo Pinto

  KEYWORDS: Lycopersicon esculentum; Antiproliferative Activity; Glioma Cell Line

  JOURNAL NAME: Food and Nutrition Sciences, Vol.4 No.6, June 7, 2013

  ABSTRACT: Among plants, the Lycopersicon esculentum (Solanaceae) is the most important for its beneficial effects on health. Several epidemiological studies have shown the benefits of tomato consumption in the cancer and cardiovascular disease prevention. Tomato products constitute the major source of lycopene, the most potent antioxidant among carotenoids in vitro. In tomatoes leaves are also present many secondary metabolites including phenolic compounds, phytoalexins, protease inhibitors and glycoalkaloids who protect against adverse effects of hosts including fungi, bacteria, viruses, and insects and are involved in host-plant resistance. In this work we evaluated the antiproliferative activity of tomato leaves extract (var. Paul Robenson) in vitro.